Commenting on amenorrhoea, or how to get sued. Five cases will be presented 25 of the audience will be asked to assess interpretative ideas or whole comments.

Slides:



Advertisements
Similar presentations
Contraception in the over 40’s
Advertisements

MANAGEMENT OF INFERTILITY CURRENT GUIDELINES
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
 Ultrasound pelvis  Full blood count  Pap smear  Coagulation profile  Liver function tests  Serum Iron  Serum ferritin  Endometrial biopsy 
The Menstrual Cycle. What is the menstrual cycle? The process in which females ripen or release one mature egg. The average menstrual cycle will repeat.
Think about… 4.1 Hormonal control of the menstrual cycle 4.2 Use of hormones Recall ‘Think about…’ Summary concept map.
Feed back control HBS3A. Simple negative feedback systems.
Are you up with the LARCs? Dr Christine Roke National Medical Advisor, Family Planning March 2011.
CASE PRESENTATION (4)(6)(7)
The Family Planning Clinic. For each of the cases Consider the factors raised by the case Advise about options, including alternatives.
SURVIVORS TEACHING STUDENTS: SAVING WOMEN’S LIVES®
HRT In a nutshell for all the blokes out there. diagnosis  Clinical hx  FSH limited value as levels fluctuate  May be of value in symtomatic women.
Session II, Slide 1 Standard Days Method (SDM) Session II: Who Can and Cannot Use SDM.
Post Menopausal Bleeding
Slide Conference Interpretation of hCG results obtained by laboratory methods Slide presentation & Music composition by: Dr. Seyed Reza Samsam Shariat.
REPRODUCTIVE HORMONE TEST REQUESTING Jeffrey Barron Consultant Chemical Pathologist Epsom & St Helier University Hospitals EFFECTIVE REPRODUCTIVE.
To treat or not to treat? Highly individualized. Debilitating symptoms. Mild symptoms.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Persistent low level hCG. four values or more of hCG plateau over at least three weeks (days 1, 7, 14, and 21 rise in hCG of 10% or greater for three.
Clinitest hCG.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Pregnancy Of Unknown Location (PUL) Dr Kamel Elbadry MD (Sheffield University), FRCOG MD (Sheffield University), FRCOG Consultant Obstetrician and Gynaecologist.
Basic Reproduction From
Menstrual Cycle and Contraception, For when it’s that time of the month! By Emilie Greenwood.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
So Which Tube Shall We Remove? A rare case of bilateral ectopic pregnancies Dr S Asif, Dr U Ijeneme and Mr S Amirchetty Department of Obstetrics and Gynaecology.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
OVARIAN CANCER RISK FACTORS Studies have found the following risk factors for ovarian cancer:  Family history of cancer: Women who have a mother, daughter,
Bleeding in Early Pregnancy
PHYSIOLOGY OF THE MENSTRUAL CYCLE
Acute Oncology Dr Nicola Storey.
The Menstrual Cycle And the Reproductive System Created by Mrs. Jane Ziemba Perryville Middle School.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Little Adult: A child with a grown up problem
Prof Lindeque Abnormal excessive uterine bleeding.
‘Let’s get it right - Referral for suspected Cancer’
Investigating infertile couple
Pregnancy Maternal and Child Nursing NUR 362 Lecture 3.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Please Be Sure You Have An Audience-Response Device (Clicker)
Suspected cancer: recognition and referral NICE guidelines [NG12] Published date: June 2015 also cancer researchuk Dr Jane Wilcock.
On behalf of the National Audit Group Dr Annie Armston, Consultant Biochemist, Southampton UHNFT and Theresa Teal, RHCH National Audit of Testing for the.
Trophoblastic disease -This is a group of disorders characterized by -This is a group of disorders characterized by 1-abnormal placental development. 1-abnormal.
Abnormal Uterine Bleeding Case Studies
What does it mean to age? Deterioration over time! This can include; weakness, susceptibility to disease, loss of mobility and agility. The reduced ability.
Biology, Grade 12 SBI4U Female Reproductive System.
Joanne Edwards Medical Information Manager ASCO Tech Assessment Update Commercial Implications & Promotional Guidance.
Investigations of infertility
Heavy menstrual bleeding Implementing NICE guidance January 2007 NICE clinical guideline 44.
Contraception in the over 40s Ruth Adams Clinical Educator Leicester Sexual Health.
Male and female sex hormones
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
ECTOPIC PREGNANCY Baher Bashity Salama Awadalla Haythm Shehabir Mahmoud Al-Shawaf.
Contraception in the over 40’s
Endometrial hyperplasia
Post Menopausal Bleeding
Diagnosis and clinical manifestation
EOL care Closing the Gap 2b.
Breast Cancer: The number speaks
Reproduction-Related Disorders
Male and Female Reproductive Health Concerns
Contraception in the over 40’s
Periods/Menstruation
Fertility Assessment & Treatment
GP Education Meeting September 2018
Takes place two weeks after consultation 2
Audit of Demand Management Strategies in York
Suspected Gynaecological Cancer Recognition & Referral
Presentation transcript:

Commenting on amenorrhoea, or how to get sued

Five cases will be presented 25 of the audience will be asked to assess interpretative ideas or whole comments on each Case. Each Case and each comment is real 25 of the audience will be asked to assess interpretative ideas or whole comments on each Case. Each Case and each comment is real Each assessor will hold up a numbered card Each assessor will hold up a numbered card The numbers range from 1 (awful) to 5 (brilliant) The numbers range from 1 (awful) to 5 (brilliant) Each assessor will not be able to see the marks given by other assessors Each assessor will not be able to see the marks given by other assessors The assessment may give us an idea of which comments are most appropriate The assessment may give us an idea of which comments are most appropriate

Case 1 A 32 year old woman, visiting her Family Doctor. Clinical information given is ’15 months amenorrhoea, cause?’ Serum results are A 32 year old woman, visiting her Family Doctor. Clinical information given is ’15 months amenorrhoea, cause?’ Serum results are Normal U & E, LFTs, TFTs Normal U & E, LFTs, TFTs HCG < 3 U/L HCG < 3 U/L LH 24 U/L, FSH 6 U/L LH 24 U/L, FSH 6 U/L Testosterone 2.5 nmol/L Testosterone 2.5 nmol/L

Interpretative ideas HCG not suggestive of pregnancy HCG not suggestive of pregnancy Early pregnancy cannot be excluded Early pregnancy cannot be excluded High LH/ FSH ratio and borderline testosterone suggestive of PCOS High LH/ FSH ratio and borderline testosterone suggestive of PCOS Possible ovulation peak Possible ovulation peak Suggest repeat in 3 months if amenorrhoea persists Suggest repeat in 3 months if amenorrhoea persists

Case 1: the outcome The patient presented to A & E 3 weeks later with abdominal pain, and although there was little radiological evidence, an ectopic pregnancy was diagnosed The patient presented to A & E 3 weeks later with abdominal pain, and although there was little radiological evidence, an ectopic pregnancy was diagnosed The patient sued the laboratory for the pain and distress caused by erroneous results/ incorrect advice The patient sued the laboratory for the pain and distress caused by erroneous results/ incorrect advice The laboratory mounted a robust defence, and the case was later dropped The laboratory mounted a robust defence, and the case was later dropped

Case 1: learning points Non-extraction female testosterone assays are of poor quality Non-extraction female testosterone assays are of poor quality The utility of an LH/ FSH ratio in diagnosing PCOS is debatable The utility of an LH/ FSH ratio in diagnosing PCOS is debatable However, with the clinical information given, PCOS was much more likely than an ovulation peak However, with the clinical information given, PCOS was much more likely than an ovulation peak But the Duty Biochemist must be very careful! But the Duty Biochemist must be very careful!

Guidelines for diagnosis of PCOS ESHRE Rotterdam 2003 consensus states that 2 of the following 3 criteria should be met: oligo/ anovulation; evidence of hyperandrogenism (either clinical or biochemical); ovarian polystic evidence on ultrasound ESHRE Rotterdam 2003 consensus states that 2 of the following 3 criteria should be met: oligo/ anovulation; evidence of hyperandrogenism (either clinical or biochemical); ovarian polystic evidence on ultrasound AACE guidelines mention that an LH/ FSH ratio of greater than 2 is seen in 60 – 70% of PCOS cases and suggest these measurements AACE guidelines mention that an LH/ FSH ratio of greater than 2 is seen in 60 – 70% of PCOS cases and suggest these measurements

Case 2 A 56 year old woman seeing her Family Doctor, clinical information ‘able to stop progesterone-only pill?’ A 56 year old woman seeing her Family Doctor, clinical information ‘able to stop progesterone-only pill?’ Serum FSH 22 U/L Serum FSH 22 U/L An FSH 5 months previously was 50 U/L An FSH 5 months previously was 50 U/L

Comments on Case 2 FSH can fluctuate markedly in the perimenopausal period. The age and FSH results suggest that the use of the progesterone-only pill for contraception is now unnecessary in this patient FSH can fluctuate markedly in the perimenopausal period. The age and FSH results suggest that the use of the progesterone-only pill for contraception is now unnecessary in this patient Previous FSH in post-menopausal period. Diagnosis of the menopause basically clinical. Results probably consistent with perimenopausal status Previous FSH in post-menopausal period. Diagnosis of the menopause basically clinical. Results probably consistent with perimenopausal status ?Suppression of FSH by exogenous oestrogens or use of creams/ herbal remedies with oestrogen-like action. If so, discontinue ?Suppression of FSH by exogenous oestrogens or use of creams/ herbal remedies with oestrogen-like action. If so, discontinue

Case 2 learning points Menopause: amenorrhoea for at least 1 year due to cessation of ovarian function in women over the age of 45 Menopause: amenorrhoea for at least 1 year due to cessation of ovarian function in women over the age of 45 Perimenopause: a span of 4 – 6 years preceding menopause when menstrual cycles may be irregular and symptoms appear such as hot flashes Perimenopause: a span of 4 – 6 years preceding menopause when menstrual cycles may be irregular and symptoms appear such as hot flashes Diagnosis is clinical (and retrospective): FSH can only be used to support the diagnosis Diagnosis is clinical (and retrospective): FSH can only be used to support the diagnosis With a raised FSH, the prudent comment is ‘FSH suggestive of (peri)menopausal status, but the possibility of further fertile cycles cannot be excluded’ With a raised FSH, the prudent comment is ‘FSH suggestive of (peri)menopausal status, but the possibility of further fertile cycles cannot be excluded’

Case 3 A 26 year old woman seeing her GP. Clinical information ‘negative pregnancy test a few days ago but period now 8 days late, breast tenderness’ A 26 year old woman seeing her GP. Clinical information ‘negative pregnancy test a few days ago but period now 8 days late, breast tenderness’ Serum hCG 122 U/L (DPC Immulite) Serum hCG 122 U/L (DPC Immulite)

Comments on Case 3 Suggest repeat serum hCG in 2 days to confirm satisfactory increase in hCG consistent with pregnancy Suggest repeat serum hCG in 2 days to confirm satisfactory increase in hCG consistent with pregnancy Please repeat in 1 week Please repeat in 1 week Possible ectopic pregnancy or missed abortion. Advise repeat in 48 hours Possible ectopic pregnancy or missed abortion. Advise repeat in 48 hours hCG result may indicate early normal uterine pregnancy or ectopic pregnancy. Suggest repeat in 48 hours which should show at least a 2fold increase if normal pregnancy hCG result may indicate early normal uterine pregnancy or ectopic pregnancy. Suggest repeat in 48 hours which should show at least a 2fold increase if normal pregnancy

Average hCG in early pregnancy Day 25:63 U/L30:240 U/L Day 25:63 U/L30:240 U/L Day 35:94040:4 300 Day 35:94040:4 300 Day 45: : Day 45: : Day 55: : Day 55: : Summarised data for the Royal Berkshire Hospital from apparently normal pregnancies (Bayer Centaur method) Summarised data for the Royal Berkshire Hospital from apparently normal pregnancies (Bayer Centaur method)

Rate of increase of hCG ‘At least doubling every 2 days’ is widely quoted ‘At least doubling every 2 days’ is widely quoted The maximum 2-day increase is 1.9 between days 35 and 45 The maximum 2-day increase is 1.9 between days 35 and 45 Before and after this period, the average rate of increase is less, and after day 60 hCG values plateau and begin to decline Before and after this period, the average rate of increase is less, and after day 60 hCG values plateau and begin to decline

Utility of this hCG data There is considerable individual variation, but because of the rapid rise, errors in dating are quite small There is considerable individual variation, but because of the rapid rise, errors in dating are quite small 67% of pregnancies give a dating within 3 days of average 67% of pregnancies give a dating within 3 days of average 95% give a dating within 9 days of average 95% give a dating within 9 days of average Bias differences between different methods make little difference Bias differences between different methods make little difference

Case 3 learning points An hCG result much less than the average value may suggest incorrect dating or an ectopic or failing pregnancy An hCG result much less than the average value may suggest incorrect dating or an ectopic or failing pregnancy In this Case, the expected hCG from the clinical information given was U/L and the possibility of an ectopic pregnancy was raised In this Case, the expected hCG from the clinical information given was U/L and the possibility of an ectopic pregnancy was raised Five days later, the patient was admitted with acute abdominal pain, and an ectopic pregnancy was identified Five days later, the patient was admitted with acute abdominal pain, and an ectopic pregnancy was identified

Case 4 A 22 year old woman seeing her GP. No clinical information was given on the request form. Serum hCG was 14 U/L A 22 year old woman seeing her GP. No clinical information was given on the request form. Serum hCG was 14 U/L Two weeks earlier, information was ‘LMP 15 weeks ago, inconclusive USS’. Serum hCG was 21 U/L Two weeks earlier, information was ‘LMP 15 weeks ago, inconclusive USS’. Serum hCG was 21 U/L Two months earlier, information was ‘?pregnant’. Serum hCG was 121 U/L Two months earlier, information was ‘?pregnant’. Serum hCG was 121 U/L

Comments on Case 4 Exclude ectopic pregnancy Exclude ectopic pregnancy Beta hCG reaches a peak at about 10 weeks in normal pregnancy and then begins to decline. These data are compatible with pregnancy. Is she likely to have another USS? Beta hCG reaches a peak at about 10 weeks in normal pregnancy and then begins to decline. These data are compatible with pregnancy. Is she likely to have another USS? Decline in hCG not consistent with pregnancy. Result suggestive of previous missed abortion or ectopic pregnancy. Please send repeat sample in 2 weeks to confirm decline in hCG Decline in hCG not consistent with pregnancy. Result suggestive of previous missed abortion or ectopic pregnancy. Please send repeat sample in 2 weeks to confirm decline in hCG Still detectable hCG may indicate retained products of conception but trophoblastic disease and possible interfering antibodies should be considered. Suggest early gynae referral Still detectable hCG may indicate retained products of conception but trophoblastic disease and possible interfering antibodies should be considered. Suggest early gynae referral

Case 4 learning points Following an abortion or termination of pregnancy, in around 65% of patients the hCG declines to non-detectable values after around 4 weeks; in at least 95% of patients after around 8 weeks Following an abortion or termination of pregnancy, in around 65% of patients the hCG declines to non-detectable values after around 4 weeks; in at least 95% of patients after around 8 weeks In the period 4 – 8 weeks after TOP with detectable hCG, it is useful to suggest a repeat hCG to confirm declining values In the period 4 – 8 weeks after TOP with detectable hCG, it is useful to suggest a repeat hCG to confirm declining values After 8 weeks, a still detectable hCG suggests either retained products of conception or a new pregnancy: a further repeat is useful After 8 weeks, a still detectable hCG suggests either retained products of conception or a new pregnancy: a further repeat is useful

Case 5 You are telephoned by a Consultant Oncologist. He has been treating a 46 year old lady for breast cancer. She finished chemotherapy 6 months ago, and is now prescribed Tamoxifen. She has had amenorrhoea for nearly a year and has menopausal symptoms. He asks which tests you would advise to check if she is menopausal You are telephoned by a Consultant Oncologist. He has been treating a 46 year old lady for breast cancer. She finished chemotherapy 6 months ago, and is now prescribed Tamoxifen. She has had amenorrhoea for nearly a year and has menopausal symptoms. He asks which tests you would advise to check if she is menopausal

Case 5 comments FSH FSH Tamoxifen can cause suppression of menstruation in pre-menopausal women. Measure TSH, T4, Prolactin, LH, FSH, E2 and progesterone Tamoxifen can cause suppression of menstruation in pre-menopausal women. Measure TSH, T4, Prolactin, LH, FSH, E2 and progesterone TSH usual test for menopause. Tamoxifen increases FSH and LH, thus FSH unreliable. No other test useful TSH usual test for menopause. Tamoxifen increases FSH and LH, thus FSH unreliable. No other test useful No test will reliably distinguish menopause from Tamoxifen side effects (FSH release induced by drug) Oestrogen Rx (o.c. or HRT) contra-indicated. If serum oestradiol is low, may help. Check TFTs No test will reliably distinguish menopause from Tamoxifen side effects (FSH release induced by drug) Oestrogen Rx (o.c. or HRT) contra-indicated. If serum oestradiol is low, may help. Check TFTs

Case 5 learning points Tamoxifen blocks oestrogen receptors, and may cause increases in both FSH and oestradiol Tamoxifen blocks oestrogen receptors, and may cause increases in both FSH and oestradiol A high FSH does not rule in the possibility of menopausal status (a low FSH may rule this out) A high FSH does not rule in the possibility of menopausal status (a low FSH may rule this out) A low oestradiol may support a diagnosis of menopause, but not conclusively so A low oestradiol may support a diagnosis of menopause, but not conclusively so

Case 5 serum results FSH 2.3 U/L; LH 5.2 U/L; oestradiol 3200 pmol/L FSH 2.3 U/L; LH 5.2 U/L; oestradiol 3200 pmol/L Two months later, FSH 21.5 U/L; LH 22.6 U/L; oestradiol 1800 pmol/L Two months later, FSH 21.5 U/L; LH 22.6 U/L; oestradiol 1800 pmol/L All results were checked at dilution and in different assay systems All results were checked at dilution and in different assay systems Do these results rule in or rule out perimenopausal status? Do these results rule in or rule out perimenopausal status? Similar interpretational problems arise in patients on progestogen-based HRT or contraception Similar interpretational problems arise in patients on progestogen-based HRT or contraception

General points Clinicians (particularly GPs) very much welcome advice in this area Clinicians (particularly GPs) very much welcome advice in this area It is difficult to provide appropriate advice It is difficult to provide appropriate advice But the Cases we find difficult are likely to be equally difficult to our Clinicians (if not even more so) But the Cases we find difficult are likely to be equally difficult to our Clinicians (if not even more so) There is no gold standard There is no gold standard Assessment of our advice is just as difficult as the advice itself! Assessment of our advice is just as difficult as the advice itself!

Thank you for listening to me